SCHEMBL17058483

SCHEMBL17058483

CC1(COc2c(N3CCN([S+]([O-])Cc4ccc([N+](=O)[O-])cc4N)CC3)cnn(-c3ccccc3)c2=O)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.35
▸ LMNA P02545 3/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ MAPT P10636 4/20 0.34
▸ ALDH1A1 P00352 6/20 0.34
▸ DCTPP1 Q9H773 4/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ NPC1 O15118 4/20 0.33
▸ RAB9A P51151 4/20 0.33
▸ PAX8 Q06710 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ CYP3A4 P08684 2/20 0.32
▸ CYP2C9 P11712 2/20 0.32
▸ CYP2C19 P33261 2/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17058191 0.92 SMN1; SMN2 (0.36) SMN1; SMN2LMNAKMT2APOLBMAPT
SCHEMBL17057817 0.90 SMN1; SMN2 (0.38) SMN1; SMN2LMNAKMT2APOLBMAPT
SCHEMBL17058457 0.88 SMN1; SMN2 (0.34) SMN1; SMN2LMNAKMT2APOLBMAPT
SCHEMBL17058487 0.85 SMN1; SMN2 (0.35) SMN1; SMN2LMNAKMT2APOLBMAPT
SCHEMBL17058438 0.85 SMN1; SMN2 (0.36) SMN1; SMN2LMNAKMT2APOLBMAPT
SCHEMBL17058224 0.85 DCTPP1 (0.40) SMN1; SMN2LMNAKMT2APOLBMAPT
SCHEMBL17058184 0.85 ALDH1A1 (0.36) SMN1; SMN2LMNAKMT2APOLBMAPT
SCHEMBL17058227 0.84 SMN1; SMN2 (0.35) SMN1; SMN2LMNAKMT2APOLBMAPT
SCHEMBL17058535 0.84 SMN1; SMN2 (0.35) SMN1; SMN2LMNAKMT2APOLBMAPT
SCHEMBL17058569 0.84 LIN28A (0.34) SMN1; SMN2LMNAKMT2APOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137179-B1 PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS MERCK SHARP & DOHME (US) 2015-09-02 — — EP disclosed
Send feedback